Optimizing Cholesterol Treatment in Patients With Muscle Complaints

Robert S Rosenson, Steven Baker, Maciej Banach, Kenneth M Borow, Lynne T Braun, Eric Bruckert, Liam R Brunham, Alberico L Catapano, Marshall B Elam, G B John Mancini, Patrick M Moriarty, Pamela B Morris, Paul Muntner, Kausik K Ray, Erik S Stroes, Beth A Taylor, Valerie H Taylor, Gerald F Watts, Paul D Thompson
Journal of the American College of Cardiology 2017 September 5, 70 (10): 1290-1301
Statins are highly effective for preventing cardiovascular events by reducing low-density lipoprotein cholesterol (LDL-C). However, many patients taking statins report muscle-related symptoms that prevent the use of guideline recommended doses. Patients with reported intolerance to statins have a high risk of cardiovascular events. Clinical strategies that optimize cardiovascular risk reduction through LDL-C lowering need to be applied in patients experiencing intolerable side effects that they attribute to statins. In this paper, the authors review definitions of statin intolerance, propose algorithms to better define statin intolerance, and describe approaches to optimize cardiovascular risk reduction among individuals reporting statin-associated muscle symptoms.


You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Available on the App Store

Available on the Play Store
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"